TY - JOUR AU - Sau, Samaresh AU - Iyer, Arun K. PY - 2018 TI - Immunotherapy and molecular role of T-cell in PD-1 antibody treated resectable lung cancer patients JF - Journal of Thoracic Disease; Vol 10, No 8 (August 29, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - In the tumor microenvironment, overexpression of check point molecules, such as program death ligand-1 (PDL1) functions as a protector against the immune surveillance by T-cell through the interaction with program death-1 (PD1) receptor (1). It has been found that PD1 overexpressed on a variety of tumor-killing immune cells, such as monocytes, macrophages, cytotoxic CD8+ T cells, and dendritic cells has an active role in hijacking the antitumor immune response (2). UR - https://jtd.amegroups.org/article/view/23135